Real-world chronic inflammatory demyelinating polyneuropathy registry
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study collects real-world information about people living with chronic inflammatory demyelinating polyneuropathy (CIDP) to help improve understanding and care. You participate from home using your smartphone, tablet, or computer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a confirmed diagnosis of CIDP from your neurologist
- You live in the United States, the United Kingdom, or Germany
- You have access to a smartphone, tablet, or computer with internet
- You are comfortable giving consent in your local language
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a blood-filtering treatment called immunoadsorption can help people with CIDP. It is for adults who are already receiving or starting IVIg or MP therapy.
This study looks at how well efgartigimod works in everyday use for people with chronic inflammatory demyelinating polyneuropathy (CIDP). It aims to understand the real-world benefits of this treatment.
This trial tests a new drug called DNTH103 for adults with CIDP, a condition that affects nerves and causes weakness. It aims to see if the drug can help people who are currently on treatment, have tried treatment before, or are new to treatment.
This trial looks at changes in nerve function and related test results in people with chronic (long-lasting) nerve problems that are getting worse. It may help researchers better understand different causes of neuropathy and how to distinguish them.
This study uses ultrasound to see how nerve inflammation changes over time in people with a chronic nerve disease called CIDP. It may help doctors choose the best treatment. The trial includes both newly diagnosed patients and those whose current treatment isn't working well.
This study looks at how well current treatments work for people with CIDP (a nerve condition causing weakness). It tracks symptoms and daily function over time to help doctors understand which treatments may work best.
Hear when a new Chronic Inflammatory Demyelinating Polyneuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.